C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2004
11/04/2004	US20040219595 Using RNA sequences to generate cDNA for use in medical diagnostics and forensics
11/04/2004	US20040219593 Biochip and method of designing probes
11/04/2004	US20040219589 Ligand profiling and identification
11/04/2004	US20040219588 Using inkjet technology to distribute reagent solution onto tissues; histology and biochemical staining; mass spectrometry; microscopy
11/04/2004	US20040219582 Diagnosing cell proliferative disorders via presence of restriction fragment length polymorphism in fibroblast growth factor (FGF-3) gene
11/04/2004	US20040219580 Determining genomic complexity of families via restriction fragment length polymorphisms, methylation profiles and transcription factor binding site analysis; forensics
11/04/2004	US20040219579 Identifying nucleic acid and protein expression profiles associated with cell proliferative and metabolic disorders; cancer associated proteins/transcripts and high throughput screening
11/04/2004	US20040219578 Method for forming microscopic polymer interconnections
11/04/2004	US20040219577 Process for the synthesis of oligomeric compounds
11/04/2004	US20040219576 Reactive functional groups
11/04/2004	US20040219575 Using presence of transcription factor/tumor antigen splice variant to diagnose cell proliferative disorders; tumor cell characterization
11/04/2004	US20040219574 Comprises oligonucleotides for detection of gram-negative bacteria and/or lactobacillus in wort/infusions used in the preparation of malted alcoholic beverages; food processing
11/04/2004	US20040219570 Methods of directed evolution
11/04/2004	US20040219569 Gene identification method
11/04/2004	US20040219567 Using genetic information to detect and physically map loci for complex traits; multi-locus alleles/genotypes and disease detection; restriction fragment length polymorphism and whole genome analysis
11/04/2004	US20040219566 Apparatus for precise data standardization and correction of global and local distortions of microarray data caused by differences in sensitivity between fluorescent dyes; standardizing gene expression intensities
11/04/2004	US20040219565 Oligonucleotides useful for detecting and analyzing nucleic acids of interest
11/04/2004	US20040219564 DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds
11/04/2004	US20040219563 Determining timing of transcriptional activation or repression of genes associated cell differentiation; identifying temporal and spatial gene expression patterns that control differentiation of stem cells; tissue engineering and therapeutic transplantation
11/04/2004	US20040219562 Novel form of the PHGPx protein as a diagnostic marker for male infertility
11/04/2004	US20040219560 Method, program and apparatus for predicting gene expression
11/04/2004	US20040219559 Using differentially methylated genomic regions (DMR) associated with insulin-like growth factor gene to diagnose/prognose colorectal and other cell proliferative disorders
11/04/2004	US20040219557 Using comparisons of hybrid melting temperatures for use in neonatal diagnosis of autosomal recessive metabolic disorder (biotinidase deficiency) occurring in 1:80,000 live births
11/04/2004	US20040219556 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
11/04/2004	US20040219555 Method of determining susceptibility to inflammatory bowel disease
11/04/2004	US20040219552 Detecting neuronal stress via monitoring in vitro expression of phosphodiesterases; diagnosis, prevention and treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; drug screening; kits
11/04/2004	US20040219550 Gedap method(genotyping based on diagnostic amplification products)for detecting and/or preventing genotyping errors from amplification products of apolymorphic locus
11/04/2004	US20040219549 Methods and nucleic acids for the differentiation of prostate and renal carcinomas
11/04/2004	US20040219548 Using presence of restriction fragment length polymorphisms in transforming growth factor, elastase, superoxide dismutase and tissue inhibitor of metalloproteinase gene or regulatory sequences to diagnose chronic obstructive pulmonary disease (COPD)
11/04/2004	US20040219547 Solid support comprising biopolymers for use in medical diagnostics, pharmaceutical development, food analysis and environmental and food technology; biosensors
11/04/2004	US20040219546 Nonspecific hydridization inhibitors, clinical examination reagents and clinical examination method
11/04/2004	US20040219545 Using RNA sequence elements to screen libraries and identify potential clones for use in pharmaceutical design and development; high throughput assay
11/04/2004	US20040219544 Amplification and detection of mycoplasma pneumoniae
11/04/2004	US20040219543 Diagnosing tumor/disease associated cells in blood sample by transferring into cells vectors comprising reporter genes that are able to identify tumor and/or disease cell specific signaling activities; prognosing tumor metastasis
11/04/2004	US20040219539 Treatment of methylated nucleic acid
11/04/2004	US20040219538 DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds
11/04/2004	US20040219537 Epidermal collection method, kit, and device
11/04/2004	US20040219534 Rapid extraction of RNA from cells and tissues
11/04/2004	US20040219533 Biological bar code
11/04/2004	US20040219532 Using unstructured nucleic acid to monitor binding events between probes and targets; drug screening, oligonucleotide sequencing
11/04/2004	US20040219530 Solid support comprising immobilized nucleotide sequences for use in detection, diagnosis and prognosis of infection and gastrointestinal disorders
11/04/2004	US20040219529 synthetic bovine Deoxyribonulease I as well as variants that are enzymatically active in hydrolyzing DNA with a catalytic profile that is distinct from that of wild type DNase I cleaving nonspecifically to release 5'-phosphorylated nucleotides
11/04/2004	US20040219528 Novel therapeutic targets in cancer
11/04/2004	US20040219527 Isolated luciferases and the use thereof
11/04/2004	US20040219526 Assay system using labeled oligonucleotides
11/04/2004	US20040219524 Nucleotide sequences complimentary to 16s ribosomal RNA of escherichia and shigella for use in diagnosis of pathogen infection
11/04/2004	US20040219523 Ligase ribozyme reporter molecule for diagnostic tool in genomic analysis
11/04/2004	US20040219520 Oligonucleotide matrix which uses changes in conductivity to detect hybridized nucleotide sequences; sequences determination
11/04/2004	US20040219518 Hepatitis F nucleotide sequences for use as tools in prevention of viral infection and cell proliferative disease; antisense agents; antiproliferative agents
11/04/2004	US20040219517 Methods for rapid identification of pathogens in humans and animals
11/04/2004	US20040219515 Human immunodeficiency viral nucleotide sequences for use as gene therapeutic tools in prevention of viral infection; gene expression inhibition
11/04/2004	US20040219513 Method of screening a metabolite of a parent candidate compound for susceptibility to biliary excretion
11/04/2004	US20040219510 Assay method for group transfer reactions
11/04/2004	US20040219509 Detecting and prognosing cerebral vasospasm via enhanced presence of transcripts associated with neural tissue injury, blood pressure regulation, coagulation and hemostasis, inflammation and apoptosis; immunoassay
11/04/2004	US20040219508 Using human liver microsomes as model system for detection of antitumor agents; mimetics; side effect reduction and anticancer agents; protein kinase c inhibition and herbal medicines
11/04/2004	US20040219361 Super-paramagnetic composite particle with core/shell structure, preparation method and use thereof
11/04/2004	US20040219287 Labelled articles and uses thereof
11/04/2004	US20040219165 Streptococcus pneumoniae antigens
11/04/2004	US20040219154 Monoclonal antibodies directed against hepatitis b viruses
11/04/2004	US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
11/04/2004	US20040219074 High density; arranged in factorial design; automated
11/04/2004	US20040217345 DNA-based memory device and method of reading and writing same
11/04/2004	US20040217019 Biosensor and method
11/04/2004	DE19610255B4 Verfahren zur Herstellung von Nukleinsäuresequenzen und Verfahren zum Nachweis von Translokationen zwischen Chromosomen Process for the preparation of nucleic acid sequences and methods for detecting translocations between chromosomes
11/04/2004	DE10318048A1 Nicht fluoreszierende, durch Proteolyse zur Fluoreszenz aktivierbare Reporterproteine und ihre Verwendung zur Detektion Protease-abhängiger Ereignisse Non-fluorescent, to be activated by proteolysis fluorescent reporter proteins and their use for the detection of protease-dependent events
11/04/2004	DE10317669A1 Verfahren zur Separierung von Detektionskanälen eines mikroskopischen Systems Process for the separation of detection channels of a microscopic system
11/04/2004	CA2526915A1 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	CA2526887A1 Splice variants of human voltage-gated calcium channel alpha2delta-2 subunit designated-alpha2delta2-a and alpha2delta2-b
11/04/2004	CA2523377A1 Influence of genotype on susceptibility to treatment with fish oil
11/04/2004	CA2522819A1 Polyvalent protein complex
11/04/2004	CA2522815A1 Analysis and use of par 1 polymorphisms for the risk estimation of cardiovascular diseases
11/04/2004	CA2522795A1 Diagnostic assay for anti-von willebrand factor cleaving protease (adamts13) antibodies
11/04/2004	CA2522753A1 Immuno-amplification
11/04/2004	CA2522730A1 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
11/04/2004	CA2522727A1 Prognosis, diagnosis and treatment of bone marrow derived stem cell associated cancer
11/04/2004	CA2522718A1 A novel method of modulating bone-related activity
11/04/2004	CA2522703A1 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
11/04/2004	CA2522701A1 Reagents and methods for detecting severe acute respiratory syndrome coronavirus
11/04/2004	CA2522700A1 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	CA2522637A1 Modified irna agents
11/04/2004	CA2522418A1 Method for characterising polynucleotides
11/04/2004	CA2522120A1 Fancc, dad1, grim19 and hadhii marker genes of psoriasis
11/04/2004	CA2521329A1 Associations of polymorphisms in the frzb gene with osteoporosis
11/04/2004	CA2521210A1 Methods for monitoring drug activities in vivo
11/04/2004	CA2520750A1 Orthogonal aminoacyl-trna synthetase
11/04/2004	CA2520146A1 Compositions and methods for determining the presence of sars coronavirus in a sample
11/04/2004	CA2519907A1 Method of inactivating ribonucleases at high temperature
11/04/2004	CA2519897A1 Modulation of telomere-initiated cell signaling
11/03/2004	EP1473370A2 Genus, group, species and/or strain specific 16S rDNA Sequences
11/03/2004	EP1473367A1 Means and methods for diagnosing and treating affective disorders
11/03/2004	EP1473364A1 Method of testing food
11/03/2004	EP1473363A1 Method of monitoring gene expression
11/03/2004	EP1473303A1 Novel proteins and dnas thereof
11/03/2004	EP1473086A1 Test tray and test system for determining response of a biological sample
11/03/2004	EP1473042A1 Controlling cholesterol catabolism via FXR receptor and screening for FXR receptor modulators
11/03/2004	EP1472545A2 Folate assay
11/03/2004	EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/03/2004	EP1472543A2 Methods and compositions involving the hsp 90 activator aha1
11/03/2004	EP1472542A2 Method for protein expression analysis
11/03/2004	EP1472541A1 Imaging agents and methods of imaging naaladase of psma

1 ... 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 ... 3003